CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-01 | Parrish Jay Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −2,315 | 37,037 | ||
| 2021-04-01 | NELSEN ROBERT Director | Other disposition | −217,781 | 12,050,547 | ||
| 2021-04-01 | NELSEN ROBERT Director | Other disposition | −282,219 | 15,616,116 | ||
| 2021-04-01 | NELSEN ROBERT Director | Other acquisition | +5,987 | 11,976 | ||
| 2021-04-01 | ARCH Venture Partners IX, LLC 10% owner | Other disposition | −217,781 | 12,050,547 | ||
| 2021-04-01 | ARCH Venture Partners IX, LLC 10% owner | Other disposition | −282,219 | 15,616,116 | ||
| 2021-04-01 | ARCH Venture Partners IX, LLC 10% owner | Other acquisition | +3,160 | 6,320 | ||
| 2021-04-01 | ARCH Venture Partners IX, LLC 10% owner | Other acquisition | +1,016 | 2,030 | ||
| 2021-03-30 | NELSEN ROBERT Director | Other disposition | −217,781 | 12,268,328 | ||
| 2021-03-30 | NELSEN ROBERT Director | Other disposition | −282,219 | 15,898,335 | ||
| 2021-03-30 | NELSEN ROBERT Director | Other acquisition | +5,989 | 5,989 | ||
| 2021-03-30 | ARCH Venture Partners IX, LLC 10% owner | Other disposition | −217,781 | 12,268,328 | ||
| 2021-03-30 | ARCH Venture Partners IX, LLC 10% owner | Other disposition | −282,219 | 15,898,335 | ||
| 2021-03-30 | ARCH Venture Partners IX, LLC 10% owner | Other acquisition | +3,160 | 3,160 | ||
| 2021-03-30 | ARCH Venture Partners IX, LLC 10% owner | Other acquisition | +1,014 | 1,014 | ||
| 2021-03-29 | HANLY ANN M. Chief Technology Officer | Grant or award | +30,000 | 30,000 | ||
| 2021-03-29 | HANLY ANN M. Chief Technology Officer | Grant or award · Employee Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2021-03-23 | Virgin Herbert EVP, Research & CSO | Option exercise | +7,900 | $1.53 | $12K | 82,100 |
| 2021-03-23 | Virgin Herbert EVP, Research & CSO | Sale | −7,900 | $53.60 | $423K | 74,200 |
| 2021-03-23 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −7,900 | 337,555 |
Page 44 of 54 · 1,063 trades